Skip to main content
. 2012 Dec 18;7(12):e51832. doi: 10.1371/journal.pone.0051832

Figure 5. In vivo expanded TRegs co-transplanted with hPBMCs are capable of preventing IL-2 accelerated GVHD in NOD-scid IL2rγcnull mice.

Figure 5

(A, B) Kaplan-Meir curve showing the survival of IL-2 conditioned NOD-scid IL2rγcnull mice injected with hPBMCs alone or hPBMCs along with in vivo expanded TRegs. TRegs purified from animals 12 days after reconstitution were used for co-transfer along with hPBMCs at 1∶1 (A) or 1∶5 (B) ratio of TRegs:PBMCs and the animals were observed for GVHD symptoms. (C, D) Kaplan-Meir curve comparing protection from GVHD conferred by in vitro and in vivo expanded TRegs. IL-2 conditioned NOD-scid IL2rγcnull mice were injected with hPBMCs only or co-transferred with different ratios of in vitro (C) or in vivo (D) expanded TRegs and hPBMCs. In all experiments, each group consisted of 3 mice.